After joining the company that became PharmaLex UK, Jon was appointed as Managing Director shortly before he reached the age of 40. He has since led the business’s strong organic and inorganic growth, achieving or exceeding the P&L targets year-on-year. On
1 January 2020, PharmaLex UK and Ireland joined forces and Jon now leads a regional organization that provides outstanding program-led and thought-leadership solutions to its clients across the PharmaLex service portfolio. Aiming to be inspirational and accessible to all parts of the organization, Jon’s colleagues know him for being both strategic and tactical with sight on the big picture as well as the detail.
During his career, Jon has supported organizations as a regulatory consultant and his clients have appreciated his commercial outlook having worked in both sales and marketing roles. With over 25 years of life sciences industry experience working for European and North American companies and clients of all sizes, Jon has covered prescription and OTC medicines, original and generic, and has provided support for registrations with an array of global regulatory authorities, across Europe, North America, the Middle East and APAC.